IMPORTANCE: In compromised corneas, eg, patients with Fuchs endothelial dystrophy (FED), it is of utmost importance to use a phacotechnique that is the least traumatic to the corneal endothelium. Furthermore, preoperative patient selection is crucial, because unexpected corneal decompensation leads to dissatisfied patients. OBJECTIVE: To compare corneal thickness and corneal volume changes using torsional and longitudinal phacoemulsification in patients with Fuchs endothelial dystrophy (FED) and determine risk factors of postoperative corneal decompensation. DESIGN, SETTING, AND PARTICIPANTS: Prospective randomized clinical trial of all patients diagnosed with FED and planning to undergo cataract surgery for visually significant cataract at a university medical center from November 2008 to May 2010. INTERVENTION: Fifty-two eyes with FED and visually significant cataract underwent torsional (n = 26) or longitudinal (n = 26) phacoemulsification. Patients were evaluated preoperatively and 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively. Visits included best spectacle-corrected visual acuity, anterior segment optical coherence tomography evaluating central corneal thickness (CCT) and peripheral corneal thickness (PCT), and Scheimpflug imaging calculating corneal volume (CV). Randomization took place according to stage of FED, nucleus density grade, and age. Intraoperatively, ultrasonography time and cumulative dissipated energy were recorded. MAIN OUTCOMES AND MEASURES: Central corneal thickness, PCT, and CV. RESULTS:Ultrasonography time and cumulative dissipated energy were significantly lower in the torsional group for harder nucleus density grades compared with the longitudinal group (P = .009 and P = .002, respectively). Peripheral corneal thickness at the 6-o'clock position, CCT, and CV were significantly smaller in the torsional group 1 day postoperatively (P = .002; P = .03; and P = .004, respectively). Changes in PCT at the 12-o'clock position and best spectacle-corrected visual acuity were not significantly different between the 2 groups (P > .05). Preoperative CCT was the only significant predictor of corneal decompensation postoperatively (P < .001). Preoperative CCT of 620 µm corresponded to an odds ratio of 1, meaning no increased risk of developing corneal decompensation. For each 10-µm increase in preoperative CCT, the odds of developing corneal decompensation increased 1.7 times. CONCLUSIONS AND RELEVANCE: Torsional phacoemulsification effectively reduces ultrasonography time and cumulative dissipated energy compared with longitudinal phacoemulsification in patients with FED. However, there were only significant differences in corneal thickness and CV changes at 1 day postoperatively in favor of the torsional group. Central corneal thickness more than 620 µm, measured by noncontact pachymetry, leads to an increased risk for corneal decompensation after phacoemulsification in patients with FED. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00781027.
RCT Entities:
IMPORTANCE: In compromised corneas, eg, patients with Fuchs endothelial dystrophy (FED), it is of utmost importance to use a phacotechnique that is the least traumatic to the corneal endothelium. Furthermore, preoperative patient selection is crucial, because unexpected corneal decompensation leads to dissatisfied patients. OBJECTIVE: To compare corneal thickness and corneal volume changes using torsional and longitudinal phacoemulsification in patients with Fuchs endothelial dystrophy (FED) and determine risk factors of postoperative corneal decompensation. DESIGN, SETTING, AND PARTICIPANTS: Prospective randomized clinical trial of all patients diagnosed with FED and planning to undergo cataract surgery for visually significant cataract at a university medical center from November 2008 to May 2010. INTERVENTION: Fifty-two eyes with FED and visually significant cataract underwent torsional (n = 26) or longitudinal (n = 26) phacoemulsification. Patients were evaluated preoperatively and 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively. Visits included best spectacle-corrected visual acuity, anterior segment optical coherence tomography evaluating central corneal thickness (CCT) and peripheral corneal thickness (PCT), and Scheimpflug imaging calculating corneal volume (CV). Randomization took place according to stage of FED, nucleus density grade, and age. Intraoperatively, ultrasonography time and cumulative dissipated energy were recorded. MAIN OUTCOMES AND MEASURES: Central corneal thickness, PCT, and CV. RESULTS: Ultrasonography time and cumulative dissipated energy were significantly lower in the torsional group for harder nucleus density grades compared with the longitudinal group (P = .009 and P = .002, respectively). Peripheral corneal thickness at the 6-o'clock position, CCT, and CV were significantly smaller in the torsional group 1 day postoperatively (P = .002; P = .03; and P = .004, respectively). Changes in PCT at the 12-o'clock position and best spectacle-corrected visual acuity were not significantly different between the 2 groups (P > .05). Preoperative CCT was the only significant predictor of corneal decompensation postoperatively (P < .001). Preoperative CCT of 620 µm corresponded to an odds ratio of 1, meaning no increased risk of developing corneal decompensation. For each 10-µm increase in preoperative CCT, the odds of developing corneal decompensation increased 1.7 times. CONCLUSIONS AND RELEVANCE: Torsional phacoemulsification effectively reduces ultrasonography time and cumulative dissipated energy compared with longitudinal phacoemulsification in patients with FED. However, there were only significant differences in corneal thickness and CV changes at 1 day postoperatively in favor of the torsional group. Central corneal thickness more than 620 µm, measured by noncontact pachymetry, leads to an increased risk for corneal decompensation after phacoemulsification in patients with FED. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00781027.
Authors: Osamah J Saeedi; Luke Y Chang; Sharon R Ong; Syed A Karim; Danielle S Abraham; Geoffrey L Rosenthal; Andrew Hammer; Brad V Spagnolo; Arturo E Betancourt Journal: Int Ophthalmol Date: 2018-07-27 Impact factor: 2.031
Authors: Tiarnan D L Keenan; Qingyu Chen; Elvira Agrón; Yih-Chung Tham; Jocelyn Hui Lin Goh; Xiaofeng Lei; Yi Pin Ng; Yong Liu; Xinxing Xu; Ching-Yu Cheng; Mukharram M Bikbov; Jost B Jonas; Sanjeeb Bhandari; Geoffrey K Broadhead; Marcus H Colyer; Jonathan Corsini; Chantal Cousineau-Krieger; William Gensheimer; David Grasic; Tania Lamba; M Teresa Magone; Michele Maiberger; Arnold Oshinsky; Boonkit Purt; Soo Y Shin; Alisa T Thavikulwat; Zhiyong Lu; Emily Y Chew Journal: Ophthalmology Date: 2022-01-03 Impact factor: 14.277
Authors: Eric D Wieben; Ross A Aleff; Bruce W Eckloff; Elizabeth J Atkinson; Saurabh Baheti; Sumit Middha; William L Brown; Sanjay V Patel; Jean-Pierre A Kocher; Keith H Baratz Journal: Invest Ophthalmol Vis Sci Date: 2014-08-28 Impact factor: 4.799
Authors: Jintang Du; Ross A Aleff; Elisabetta Soragni; Krishna Kalari; Jinfu Nie; Xiaojia Tang; Jaime Davila; Jean-Pierre Kocher; Sanjay V Patel; Joel M Gottesfeld; Keith H Baratz; Eric D Wieben Journal: J Biol Chem Date: 2015-01-15 Impact factor: 5.157